The labelling intensity of CPLX1, STX1A, SYT1 and SYNGR1 was significantly reduced in the OML of AD compared to control cases (Fig. 1), corroborating our previous proteomics findings.17 This evidence concerns the gene CPLX1 and Alzheimer disease.